Design, Synthesis, and Cholinesterase Inhibitory Evaluation of Novel 5-(Benzylthio)-1,3,4-thiadiazole Derivatives
Abstract
Alzheimer's disease remains one of the leading causes of dementia, and the development of novel cholinesterase inhibitors continues to attract considerable interest for symptomatic treatment. In this study, a series of five novel 5-(benzylthio)-1,3,4-thiadiazole derivatives bearing different nitrogen-containing substituents was designed, synthesized, and evaluated for their cholinesterase inhibitory activities. The target compounds were prepared through a straightforward synthetic route involving S-benzylation of 2-amino-5-mercapto-1,3,4-thiadiazole, followed by acylation and nucleophilic substitution using various amine derivatives. All compounds were obtained in moderate to good yields and fully characterized by LC-MS, 1H NMR, and 13C NMR spectroscopy. Their inhibitory activities against acetylcholinesterase and butyrylcholinesterase were determined using a modified Ellman's assay. The synthesized derivatives generally exhibited negligible AChE inhibitory activity. In contrast, differences in the terminal amine moiety influenced BChE inhibition, with the tetrahydroisoquinoline-containing derivative, compound 4, displaying the highest activity within the series. Compound 4 showed concentration-dependent BChE inhibition, reaching 83% inhibition at 50 µM and exhibiting an IC50 value of 10.63 µM. The remaining derivatives showed little or no significant inhibition toward either enzyme under the tested conditions. These findings suggest that the tetrahydroisoquinoline scaffold may represent a promising structural motif for further optimization toward selective BChE inhibitor. Overall, this study provides a convenient synthetic platform for the development of new 5-(benzylthio)-1,3,4-thiadiazole derivatives and identifies compound 4 as a suitable lead for future structure optimization and detailed biological investigation.
Keywords
amines, enzyme assays, neurodegenerative diseases, thiadiazoles
References
- Babalola, B. A., Sharma, L., Olowokere, O., Malik, M., & Folajimi, O. (2024). Advancing drug discovery: Thiadiazole derivatives as multifaceted agents in medicinal chemistry and pharmacology. Bioorganic & Medicinal Chemistry, 112, 117876. https://doi.org/10.1016/j.bmc.2024.117876
- Clive, G. B., Nigel, H. G., Angela, L. G.-B., Albert, E., & Sultan, D. (2005). Cholinesterases: Roles in the Brain During Health and Disease. Current Alzheimer Research, 2(3), 307-318. http://dx.doi.org/10.2174/1567205054367838
- Dimkovski, A., Dobričić, V., Simić, M. R., Jurhar Pavlova, M., Mihajloska, E., Sterjev, Z., & Poceva Panovska, A. (2025). Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Coumarin–Triazole–Isatin Hybrids as Selective Butyrylcholinesterase Inhibitors. Molecules, 30(10), 2121. https://doi.org/10.3390/molecules30102121
- Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology, 7(2), 88-95. https://doi.org/10.1016/0006-2952(61)90145-9
- Greig, N. H., Lahiri, D. K., & Kumar, S. (2002). Butyrylcholinesterase: An Important New Target in Alzheimer’s Disease Therapy. International Psychogeriatrics, 14, 77-91. https://doi.org/10.1017/S1041610203008676
- Greig, N. H., Utsuki, T., Ingram, D. K., Wang, Y., Pepeu, G., Scali, C., Yu, Q.-S., Mamczarz, J., Holloway, H. W., Giordano, T., Chen, D., Furukawa, K., Sambamurti, K., Brossi, A., & Lahiri, D. K. (2005). Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent. Proceedings of the National Academy of Sciences, 102(47), 17213-17218. https://doi.org/10.1073/pnas.0508575102
- Haider, S., Alam, M. S., Hamid, H., Dhulap, A., & Kumar, D. (2019). Design, synthesis and biological evaluation of benzoxazolinone-containing 1,3,4-thiadiazoles as TNF-α inhibitors. Heliyon, 5(4), e01503. https://doi.org/10.1016/j.heliyon.2019.e01503
- Kilic, B., Bardakkaya, M., Ilıkcı Sagkan, R., Aksakal, F., Shakila, S., & Dogruer, D. S. (2023). New thiourea and benzamide derivatives of 2-aminothiazole as multi-target agents against Alzheimer's disease: Design, synthesis, and biological evaluation. Bioorganic Chemistry, 131, 106322. https://doi.org/10.1016/j.bioorg.2022.106322
- Kumar, A., Pintus, F., Di Petrillo, A., Medda, R., Caria, P., Matos, M. J., Viña, D., Pieroni, E., Delogu, F., Era, B., Delogu, G. L., & Fais, A. (2018). Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease. Scientific Reports, 8(1), 4424. https://doi.org/10.1038/s41598-018-22747-2
- Law, C. S. W., Ha, Z. Y., Brazzolotto, X., & Yeong, K. Y. (2026). Structure-guided design and synthesis of selective butyrylcholinesterase inhibitors. Journal of Molecular Structure, 1360, 145611. https://doi.org/https://doi.org/10.1016/j.molstruc.2026.145611